Granisetron

In the US, Granisetron (granisetron systemic) is a member of the drug class 5HT3 receptor antagonists and is used to treat Nausea/Vomiting - Chemotherapy Induced, Nausea/Vomiting - Postoperative and Nausea/Vomiting - Radiation Induced.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A04AA02

CAS registry number (Chemical Abstracts Service)

0109889-09-0

Chemical Formula

C18-H24-N4-O

Molecular Weight

312

Therapeutic Categories

Antiemetic agent

Serotonin 5HT₃-receptor antagonist

Chemical Name

1-Methyl-N-(endo-9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide

Foreign Names

  • Granisetronum (Latin)
  • Granisetron (German)
  • Granisétron (French)
  • Granisetron (Spanish)

Generic Names

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web5)